Xylyx Bio, Inc.

Xylyx Bio, Inc. is a dynamic biotechnology company focused on regenerative medicine, pioneering innovative approaches to tissue repair and regeneration. Located in Brooklyn, New York, at its primary address of 760 Parkside Ave, Xylyx Bio is dedicated to eliminating transplant waiting list mortality and significantly reducing healthcare costs through the bioengineering of human whole organ grafts for life-saving transplantation.

Xylyx Bio specializes in a range of advanced technologies, including donor organ repair, organ transplant solutions, fibrosis research, and the development of sophisticated disease models. By leveraging cutting-edge tissue engineering and biomaterials, Xylyx Bio is at the forefront of preclinical models, cancer research, and drug development. The company’s expertise in extracellular matrix and organ perfusion techniques drives its commitment to transforming healthcare.

Xylyx Bio's innovative work promises to revolutionize the field of regenerative medicine, offering hope to patients worldwide. We invite the management team at Xylyx Bio, Inc. to create a customized and exclusive company showcase and product listing on our platform, to highlight their remarkable achievements and further expand their commercial presence.